-
Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Results From Hypertension Study
Monday, April 18, 2022 - 2:15pm | 831Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released data from its HYPER-H21-3 human study. The company noted that...
-
GreenBox (NASDAQ: GBOX) Completes SOC Certification Audit
Wednesday, April 13, 2022 - 3:06pm | 775Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has completed the System and Organization Controls (“SOC”) 2 Type 2...
-
Cybin's (NYSE American: CYBN) (NEO: CYBN) CYB004 Demonstrates Advantages in Study
Wednesday, April 13, 2022 - 3:02pm | 833Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced...
-
Energy Fuels (NYSE American: UUUU) (TSX: EFR) Completes Shipments Of Uranium, Vanadium, REE
Wednesday, April 13, 2022 - 3:00pm | 1104Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, hit a critical mineral “trifecta” this month,...
-
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
Wednesday, April 13, 2022 - 2:56pm | 831Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria Bioscience (NASDAQ: LEXX) (NASDAQ: LEXXW), a global innovator in drug delivery platforms, today announced details of human nicotine study NIC-H22-1,...
-
CNS Pharmaceuticals (NASDAQ: CNSP) To Participate In Upcoming Virtual Investor Event
Tuesday, April 12, 2022 - 3:19pm | 851Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the...
-
Knightscope (NASDAQ: KSCP) Better Equips Itself For Long-Term Growth Plans
Tuesday, April 12, 2022 - 3:14pm | 765Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies committed to enhancing U.S. security operations, has promoted four employees...
-
Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program
Tuesday, April 12, 2022 - 3:09pm | 723Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has entered agreements with Altria Client Services LLC. According to the...
-
GreenBox (NASDAQ: GBOX) Names Seasoned Transactional Attorney To Board Of Directors
Tuesday, April 12, 2022 - 3:03pm | 841Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has named a new member of its board of directors. The company has appointed...
-
General Mills Inc. (GIS) Climbs to Annual-High Share Price
Monday, April 11, 2022 - 2:06pm | 620Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of General Mills Inc. (NYSE: GIS) traded at a new 12-month high today of $70.94. So far today approximately 489,000 shares have been exchanged, as...
-
Watch For Continued Gains In Shares Of GlaxoSmithKline PLC (GSK)
Monday, April 11, 2022 - 1:48pm | 564Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Shares of GlaxoSmithKline PLC (NYSE: GSK) traded at a new 12-month high today of $46.97. Approximately 1.1 million shares have changed hands today, as compared...
-
Lucid Motors (NASDAQ: LCID) Ramps Up Marketing To Increase Awareness Of Its EVs
Monday, April 11, 2022 - 1:29pm | 527Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. More than a decade after the Tesla Roadster launched and proved that electric vehicles were commercially viable, the nascent electric vehicle industry is slowly...
-
Cybin (NYSE American: CYBN) (NEO: CYBN) Strengthens IP Position Of Psychedelic Programs
Friday, April 8, 2022 - 2:25pm | 802Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced...
-
Knightscope (NASDAQ: KSCP) To Kick Off Spring Robot Roadshow as Part of Marketing Campaign
Friday, April 8, 2022 - 2:17pm | 742Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Knightscope’s spring Robot Roadshow is set to kick off on April 12, and will cover key states in the U.S. before making it to the capital for National...
-
Cepton (NASDAQ: CPTN) Poised To Increase Visibility In Autonomous Driving
Friday, April 8, 2022 - 2:14pm | 814Read More...This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice. Cepton continues to be at forefront of state-of-the-art engineering science; sponsors The AutoDrive Challenge(TM) II and serves as an exclusive LiDAR supplier...
















